Association of Polymorphic Variants of <i>VEGF</i> and <i>KDR</i> Genes with Development and Metastasing of Non-Small Cell Lung Cancer — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Association of Polymorphic Variants of <i>VEGF</i> and <i>KDR</i> Genes with Development and Metastasing of Non-Small Cell Lung Cancer
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
,
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
,
Belarusian State Medical University, Minsk, Republic of Belarus
,
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
,
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
,
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
1 Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
2 Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
3 Belarusian State Medical University, Minsk, Republic of Belarus
4 Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
5 Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
6 Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Republic of Belarus
Vascular endothelial growth factor (VEGF) is one of the most important and specific factors affecting angiogenesis in tumor development. VEGFR2 is a receptor encoded by the KDR gene. VEGF and VEGFR2 transmit a signal to intracellular tyrosine kinase cascades. Polymorphic variants of the VEGF and KDR genes significantly influence the expression levels of the endothelial growth factor and its receptor, which leads to a change in the activation of angiogenesis in oncopathological processes. In this study, the relationship between the polymorphic variants rs2010963, rs699947 and rs3025039 of the VEGF gene and rs1870377 and rs2071559 of the KDR gene was analyzed with the development of a specific histological type of non-small cell lung cancer and its clinical and morphological characteristics. It was established that the development of squamous cell carcinoma is associated with -634CC genotype of the VEGF gene and the genotypes containing -2578A allele of the VEGF gene reduce the likelihood of this cancer type development. The development of adenocarcinoma is associated with +936CC VEGF /1719TT KDR and +936CT VEGF /1719TT KDR combinations. In women with non-small cell lung cancer, -634GC genotype of the VEG F gene is associated with a greater degree of the primary lesion spread. Genotype -2578 СС of the VEGF gene is associated with a higher degree of the primary tumor spread in the general group of patients and with regional metastases in women. Haplotypes -634G/-2578C/+936C are risky for the occurrence of metastases in regional lymph nodes in women.
Larsen, J.E. and Minna, J.D. (2011) Molecular Biology of lung Cancer: Clinical Implications. Clinics in Chest Medicine, 32, 703-740. https://doi.org/10.1016/j.ccm.2011.08.003
Jussila, L. and Alitalo, K. (2002) Vascular Growth Factors and Lymphangiogenesis. Physiological Reviews, 82, 673-700. https://doi.org/10.1152/physrev.00005.2002
Chen, Q., Zhou, Z. and Shan, L. (2014) Association of the Vascular Endothelial Growth Factor -2578C/A Polymorphism with Cancer Risk: A Meta-Analysis Update. Biomedical Reports, 2, 823-830. https://doi.org/10.3892/br.2014.317
Han, S.W., Kim, G.W., Seo, J.S., Kim, S.J., Sa, K.H., Park, J.Y., Lee, J., Kim, S.Y., Goronzy, J.J., Weyand, C.M. and Kang, Y.M. (2004) VEGF Gene Polymorphisms and Susceptibility to Rheumatoid Arthritis. Rheumatology, 43, 1173-1177. https://doi.org/10.1093/rheumatology/keh281
Ferrara, N. (2002) VEGF and the Quest for Tumour Angiogenesis Factors. Nature Reviews Cancer, 2, 795-803. https://doi.org/10.1038/nrc909
Ferrara, N., Gerber, H.P. and LeCouter, J. (2003) The Biology of VEGF and Its Receptors. Nature Medicine, 9, 669-676. https://doi.org/10.1038/nm0603-669
Yamamori, M., Sakaeda, T., Nakamura, T., Okamura, N., Tamura, T., Aoyama, N., Kamigaki, T., et al. (2004) Association of VEGF Genotype with mRNA Level in Colorectal Adenocarcinomas. Biochemical and Biophysical Research Communications, 325, 144-150. https://doi.org/10.1016/j.bbrc.2004.10.005
Sait, S.N.J., Dougher-Vermazen, M., Shows, T.B. and Terman, B.I. (1995) The Kinase Insert Domain Receptor Gene (KDR) Has Been Relocated to Chromosome 4q11-q12. Cytogenet Cell Genet, 70, 145-146. https://doi.org/10.1159/000134081
Mathew, C.C. (1984) The Isolation of High Molecular Weight Eucaryotic DNA. Methods in Molecular Biology, 2, 31-34.
Sole, X., Guino, E., Valls, J., Iniesta, R. and Moreno, V. (2006) SNPStats: A Web Tool for the Analysis of Association Studies. Bioinformatics, 22, 1928-1929. https://doi.org/10.1093/bioinformatics/btl268
Langsenlehner, U., Hofmann, G., Renner, W., Gerger, A., Krenn-Pilko, S., Thurner, E.M., Krippl, P. and Langsenlehner, T. (2015) Association of Vascular Endothelial Growth Factor: A Gene Polymorphisms and Haplotypes with Breast Cancer Metastases. Acta Oncologica, 54, 368-376. https://doi.org/10.3109/0284186X.2014.948056
Sa-Nguanraksa, D., Kooptiwut, S., Chuangsuwanich, T., Pongpruttipan, T., Malasit, P. and O-Charoenrat, P. (2014) Vascular Endothelial Growth Factor Polymorphisms Affect Gene Expression and Tumor Aggressiveness in Patients with Breast Cancer. Molecular Medicine Reports, 9, 1044-1048. https://doi.org/10.3892/mmr.2014.1890
Gene Polymorphism
Naykoo, N.A., Dil-Afroze, Rasool, R., Shah, S., Ahangar, A.G., Bhat, I.A., Qasim, I., Siddiqi, M.A. and Shah, Z.A. (2017) Single Nucleotide Polymorphisms, Haplotype Association and Tumour Expression of the Vascular Endothelial Growth Factor (VEGF) Gene with Lung Carcinoma. Gene, 608, 95-102. https://doi.org/10.1016/j.gene.2017.01.007
Li, Y., Liang, J., Liu, X., Liu, H., Yin, B., Xiao, J. and Bi, Z. (2012) Correlation of Polymorphisms of the Vascular Endothelial Growth Factor Gene and the Risk of Lung Cancer in an Ethnic Han Group of North China. Experimental and Therapeutic Medicine, 3, 673-676. https://doi.org/10.3892/etm.2012.453
Jin, Q., Hemminki, K., Enquist, K., Lenner, P., Grzybowska, E., Klaes, R., Henriksson, R., Chen, B., Pamula, J., Pekala, W., Zientek, H., Rogozinska-Szczepka, J., Utracka-Hutka, B., Hallmans, G. and Forsti, A. (2005) Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis. Clinical Cancer Research, 11, 3647-3653. https://doi.org/10.1158/1078-0432.CCR-04-1803
Liu, D.H., Zhang, X.Y., Fan, D.M., Huang, Y.X., Zhang, J.S., Huang, W.Q., Jin, M., et al. (2001) Expression of Vascular Endothelial Growth Factor and Its Role in Oncogenesis of Human Gastric Carcinoma. World Journal of Gastroenterology, 7, 500-505. https://doi.org/10.3748/wjg.v7.i4.500
Koukourakis, M.I., Papazoglou, D., Giatromanolaki, A., Bougioukas, G., Maltezos, E. and Sivridis, E. (2004) VEGF Gene Sequence Variation Defines VEGF Gene Expression Status and Angiogenic Activity in Non-Small Cell Lung Cancer. Lung Cancer, 46, 293-298. https://doi.org/10.1016/j.lungcan.2004.04.037
Shahbazi, M., Fryer, A.A., Pravica, V., Brogan, I.J., Ramsay, H.M., Hutchinson, I.V. and Harden, P.N. (2002) Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Acute Renal Allograft Rejection. Journal of the American Society of Nephrology, 13, 260-264.
Deng, Z.C., Cao, C., Yu, Y.M., Ma, H.Y. and Ye, M. (2014) Vascular Endothelial Growth Factor—634G/C and Vascular Endothelial Growth Factor—2578C/A Polymorphisms and Lung Cancer Risk: A Case-Control Study and Meta-Analysis. Tumor Biology, 35, 1805-1811. https://doi.org/10.1007/s13277-013-1241-x
Renner, W., Kotschan, S., Hoffmann, C., Obermayer-Pietsch, B. and Pilger, E. (2000) A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma Levels. Journal of Vascular Research, 37, 443-448. https://doi.org/10.1159/000054076
Krippl, P., Langsenlehner, U., Renner, W., Yazdani-Biuki, B., Wolf, G., Wascher, T.C., Paulweber, B., Haas, J. and Samonigg, H. (2003) A Common 936 C/T Gene Polymorphism of Vascular Endothelial Growth Factor Is Associated with Decreased Breast Cancer Risk. International Journal of Cancer, 106, 468-471. https://doi.org/10.1002/ijc.11238
Hammerschmidt, S. (2009) Lung Cancer: Current Diagnosis and Treatment. Deutsches Arzteblatt International, 106, 809-818.
Slattery, M.L., Lundgreen, A. and Wolff, R.K. (2014) VEGFA, FLT1, KDR and Colorectal Cancer: Assessment of Disease Risk, Tumor Molecular Phenotype, and Survival. Molecular Carcinogenesis, 53, 140-150. https://doi.org/10.1002/mc.22058
Slattery, M.L., John, E.M., Torres-Mejia, G., Lundgreen, A., Lewinger, J.P., Stern, M., Wolff, R.K., et al. (2014) Angiogenesis Genes, Dietary Oxidative Balance, and Breast Cancer Risk and Progression: The Breast Cancer Health Disparities Study. Journal International Du Cancer, 134, 629-644. https://doi.org/10.1002/ijc.28377
Lu, H., Shu, X.O., Cui, Y., Kataoka, N., Wen, W., Cai, Q., Ruan, Z.X., Gao, Y.T. and Zheng, W. (2005) Association of Genetic Polymorphisms in the VEGF Gene with Breast Cancer Survival. Cancer Research, 65, 5015-5019. https://doi.org/10.1158/0008-5472.CAN-04-2786